Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 9,000 shares at $39.85 ($359K) on 2016-03-01, disclosed to the SEC on 2016-03-02.
Open-market sale of $359k INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INCR | SELL | 2016-02-02 | $365K | — | Filing → |
| INCR | SELL | 2016-01-06 | $421K | — | Filing → |
| INCR | SELL | 2015-12-03 | $419K | — | Filing → |